Clinical trial
A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy…
NCT00398996 · Centre for the AIDS Programme of Research in South Africa, Other · Completed
Key facts
| NCT number | NCT00398996 |
|---|---|
| Title | A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients |
| Official title | Study to Compare Three Existing Starting Points of ART Initiation in HIV/TB Co-infected Patients |
| Acronym | SAPIT |
| Lead sponsor | Centre for the AIDS Programme of Research in South Africa, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections, Tuberculosis |
| Intervention type | Drug |
| Interventions | Early versus intermediate versus late initiation of ART |
| Enrollment | 642 |
| Start date | Jun 1, 2005 |
| Primary completion | Jul 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | Nov 14, 2006 |
| Last update posted | Mar 24, 2011 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: